2012
DOI: 10.3389/fphys.2012.00008
|View full text |Cite
|
Sign up to set email alerts
|

The Membrane-Bound Aspartyl Protease BACE1: Molecular and Functional Properties in Alzheimer’s Disease and Beyond

Abstract: The β-site APP cleaving enzyme 1 (BACE1) is a transmembrane aspartyl protease involved in Alzheimer’s disease (AD) pathogenesis and in myelination. BACE1 initiates the generation of the pathogenic amyloid β-peptide, which makes BACE1 a major drug target for AD. BACE1 also cleaves and activates neuregulin 1, thereby contributing to postnatal myelination, in particular in the peripheral nervous system. Additional proteins are also cleaved by BACE1, but less is known about the physiological consequences of their … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

2
51
0

Year Published

2012
2012
2023
2023

Publication Types

Select...
6
4

Relationship

1
9

Authors

Journals

citations
Cited by 74 publications
(54 citation statements)
references
References 229 publications
2
51
0
Order By: Relevance
“…In the AD brain, the BACE1 protein, not its mRNA levels, have been shown to be up-regulated (20,21). Several proteins, such as translation initiation factor eIF2␣ (22,23), Golgi-localized ␥-ear-containing ADP-ribosylation factor binding (GGA), the reticulon/Nogo family of proteins, Arf6, and sortilins, are implicated in the stability and intracellular localization of BACE1 (24 -27), but the mechanism, as well as their putative coordinated actions, remains unclear. Efforts are underway to develop drugs that would block BACE1 to prevent the generation of A␤ and alleviate the associated cognitive symptoms in AD (28,29).…”
mentioning
confidence: 99%
“…In the AD brain, the BACE1 protein, not its mRNA levels, have been shown to be up-regulated (20,21). Several proteins, such as translation initiation factor eIF2␣ (22,23), Golgi-localized ␥-ear-containing ADP-ribosylation factor binding (GGA), the reticulon/Nogo family of proteins, Arf6, and sortilins, are implicated in the stability and intracellular localization of BACE1 (24 -27), but the mechanism, as well as their putative coordinated actions, remains unclear. Efforts are underway to develop drugs that would block BACE1 to prevent the generation of A␤ and alleviate the associated cognitive symptoms in AD (28,29).…”
mentioning
confidence: 99%
“…Distinct sheddases may participate in intercalating processes, with disparate physiological consequences: ADAM-9, -10 (α-secretases), and -17 contribute to the nonamyloidogenic pathway of human amyloid precursor protein (APP) processing, whereas BACE-1 (β-secretase) participates in the amyloidogenic pathway. Whereas the former generates innocuous peptides, the latter gives rise to the toxic β-amyloid peptides believed to be responsible for Alzheimer's disease (11). In several instances, shedding at the membrane surface is followed by a "regulated intramembrane proteolysis" step within the membrane (1).…”
mentioning
confidence: 99%
“…Plasma membrane acts as a selective barrier as well as means of communication with extracellular environment through signal transduction in a cell (Harder, 2012; Astro and de Curtis, 2015). In addition, membranes compartmentalize eukaryotic cell into different subcellular structures and act as scaffold for certain enzymatic reactions that allow reactions to be spatially confined inside a cell and 3-D cytosol to 2D membrane (Dislich and Lichtenthaler, 2012), respectively.…”
Section: Introductionmentioning
confidence: 99%